Gastrointestinal Therapeutics Market Size, Share & Trends Report

Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report By Type, By Drug Class, By Application (Crohn’s Disease, Ulcerative Colitis, GERD), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-2-68038-338-6
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Gastrointestinal Therapeutics Market Type Outlook (Revenue, USD Million, 2018 - 2030) (Number of Patients in Million)
- Branded
- Generics
Gastrointestinal Therapeutics Market Drug ClassOutlook (Revenue, USD Million, 2018 - 2030)
- Aminosalicylates
- Digestive enzymes
- Proton Pump Inhibitors
- Laxatives
- Anti-Emetics
- H2 Antagonists
- Anti-Diarrheal
- Biologics/Biosimilar
- Others
Gastrointestinal Therapeutics Market Route of Administration Outlook (Revenue, USD Million, 2018 - 2030) (Number of Patients in Million)
- Oral
- Injectable
- Others
Gastrointestinal Therapeutics Market Application Outlook (Revenue, USD Million, 2018 - 2030) (Number of Patients by Type in Million)
- Crohn's disease
- Ulcerative colitis
- GERD
- IBS
- Others
Gastrointestinal Therapeutics Market Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Gastrointestinal Therapeutics Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Branded
    - Generics
  - North America Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
    - Aminosalicylates
    - Digestive enzymes
    - Proton Pump Inhibitors
    - Laxatives
    - Anti-Emetics
    - H2 Antagonists
    - Anti-Diarrheal
    - Biologics/Biosimilar
    - Others
  - North America Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Oral
    - Injectable
    - Others
  - North America Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
    - Crohn's disease
    - Ulcerative colitis
    - GERD
    - IBS
    - Others
  - North America Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - U.S.
    - U.S. Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - U.S. Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - U.S. Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - U.S. Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - U.S. Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Canada
    - Canada Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Canada Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Canada Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Canada Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Canada Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
- Europe
  - Europe Gastrointestinal Therapeutics Market, By Country 2018 - 2030 (USD Million)
    - Germany
    - UK
    - France
    - Italy
    - Spain
    - Denmark
    - Sweden
    - Norway
  - Europe Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Branded
    - Generics
  - Europe Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
    - Aminosalicylates
    - Digestive enzymes
    - Proton Pump Inhibitors
    - Laxatives
    - Anti-Emetics
    - H2 Antagonists
    - Anti-Diarrheal
    - Biologics/Biosimilar
    - Others
  - Europe Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Oral
    - Injectable
    - Others
  - Europe Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
    - Crohn's disease
    - Ulcerative colitis
    - GERD
    - IBS
    - Others
  - Europe Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - Germany
    - Germany Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Germany Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Germany Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Germany Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Germany Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - UK
    - UK Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - UK Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - UK Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - UK Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - UK Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - France
    - France Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - France Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - France Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - France Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - France Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Italy
    - Italy Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Italy Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Italy Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Italy Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Italy Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Spain
    - Spain Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Spain Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Spain Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Spain Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Spain Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Denmark
    - Denmark Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Denmark Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Denmark Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Denmark Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Denmark Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Sweden
    - Sweden Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Sweden Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Sweden Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Sweden Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Sweden Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Norway
    - Norway Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Norway Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Norway Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Norway Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Norway Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
- Asia Pacific
  - Asia Pacific Gastrointestinal Therapeutics Market, By Country 2018 - 2030 (USD Million)
    - Japan
    - China
    - India
    - South Korea
    - Australia
    - Thailand
  - Asia Pacific Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Branded
    - Generics
  - Asia Pacific Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
    - Aminosalicylates
    - Digestive enzymes
    - Proton Pump Inhibitors
    - Laxatives
    - Anti-Emetics
    - H2 Antagonists
    - Anti-Diarrheal
    - Biologics/Biosimilar
    - Others
  - Asia Pacific Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Oral
    - Injectable
    - Others
  - Asia Pacific Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
    - Crohn's disease
    - Ulcerative colitis
    - GERD
    - IBS
    - Others
  - Asia Pacific Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - Japan
    - Japan Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Japan Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Japan Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Japan Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Japan Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - China
    - China Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - China Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - China Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - China Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - China Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - India
    - India Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - India Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - India Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - India Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - India Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - South Korea
    - South Korea Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - South Korea Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - South Korea Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - South Korea Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - South Korea Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Australia
    - Australia Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Australia Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Australia Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Australia Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Australia Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Thailand
    - Thailand Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Thailand Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Thailand Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Thailand Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Thailand Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
- Latin America
  - Latin America Gastrointestinal Therapeutics Market, By Country 2018 - 2030 (USD Million)
    - Mexico
    - Brazil
    - Argentina
  - Latin America Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Branded
    - Generics
  - Latin America Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
    - Aminosalicylates
    - Digestive enzymes
    - Proton Pump Inhibitors
    - Laxatives
    - Anti-Emetics
    - H2 Antagonists
    - Anti-Diarrheal
    - Biologics/Biosimilar
    - Others
  - Latin America Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Oral
    - Injectable
    - Others
  - Latin America Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
    - Crohn's disease
    - Ulcerative colitis
    - GERD
    - IBS
    - Others
  - Latin America Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - Mexico
    - Mexico Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Mexico Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Mexico Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Mexico Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Mexico Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Brazil
    - Brazil Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Brazil Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Brazil Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Brazil Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Brazil Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Argentina
    - Argentina Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Argentina Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Argentina Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Argentina Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Argentina Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
- Middle East and Africa
  - Middle East and Africa Gastrointestinal Therapeutics Market, By Country 2018 - 2030 (USD Million)
    - South Africa
    - Saudi Arabia
    - UAE
    - Kuwait
  - Middle East and Africa Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Branded
    - Generics
  - Middle East and Africa Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
    - Aminosalicylates
    - Digestive enzymes
    - Proton Pump Inhibitors
    - Laxatives
    - Anti-Emetics
    - H2 Antagonists
    - Anti-Diarrheal
    - Biologics/Biosimilar
    - Others
  - Middle East and Africa Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
    - Oral
    - Injectable
    - Others
  - Middle East and Africa Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
    - Crohn's disease
    - Ulcerative colitis
    - GERD
    - IBS
    - Others
  - Middle East and Africa Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - South Africa
    - South Africa Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - South Africa Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - South Africa Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - South Africa Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - South Africa Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Saudi Arabia
    - Saudi Arabia Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Saudi Arabia Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Saudi Arabia Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Saudi Arabia Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Saudi Arabia Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - UAE
    - UAE Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - UAE Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - UAE Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - UAE Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - UAE Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies
  - Kuwait
    - Kuwait Gastrointestinal Therapeutics Market, By Type, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Branded
      - Generics
    - Kuwait Gastrointestinal Therapeutics Market, By Drug Class, 2018 - 2030 (USD Million)
      - Aminosalicylates
      - Digestive enzymes
      - Proton Pump Inhibitors
      - Laxatives
      - Anti-Emetics
      - H2 Antagonists
      - Anti-Diarrheal
      - Biologics/Biosimilar
      - Others
    - Kuwait Gastrointestinal Therapeutics Market, By Route of Administration, 2018 - 2030 (USD Million) (Number of Patients in Million)
      - Oral
      - Injectable
      - Others
    - Kuwait Gastrointestinal Therapeutics Market, By Application, 2018 - 2030 (USD Million) (Number of Patients by Type in Million)
      - Crohn's disease
      - Ulcerative colitis
      - GERD
      - IBS
      - Others
    - Kuwait Gastrointestinal Therapeutics Market, By Distribution Channel, 2018 - 2030 (USD Million)
      - Hospital Pharmacies
      - Retail Pharmacies
      - Online Pharmacies

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.